The leukemia controversy in myeloproliferative disorders: Is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The leukemia controversy in myeloproliferative disorders: Is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?

Published:2004-04 Issue: Volume:41 Page:15-17
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Barbui Tiziano

Publisher

Elsevier BV

Subject

Hematology

Reference10 articles.

1. No treatment for low risk thrombocythemia;Ruggeri;Br J Haematol,1998

2. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols;Berk;Semin Hematol,1986

3. From efficacy to safety;Fruchtman;Semin Hematol,1997

4. Treatment of polycythemia vera;Najean;Blood,1977

5. Interferon-α2b;Silver;Ann Intern Med,1993

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report;Frontiers in Oncology;2024-01-09

2. Management of hydroxyurea resistant or intolerant polycythemia vera;Leukemia & Lymphoma;2021-05-05

3. How I treat the blast phase of Philadelphia chromosome–negative myeloproliferative neoplasms;Blood;2018-11-29

4. Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study;Leukemia Research;2018-11

5. Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations;Current Hematologic Malignancy Reports;2018-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP